You have selected a link to an external website. In a few moments you will be redirected to http:/news.investors.com/newsfeed-business-wire/022213-141440594-fda-approves-genentech-s-kadcyla-ado-trastuzumab-emtansine-the-first-antibody-drug-conjugate-for-treating-her2-positive-metastatic-breast-cancer.asp